---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-024381"
form_type: "8-K"
ticker: "IDXG"
cik: "0001054102"
company_name: "INTERPACE BIOSCIENCES, INC."
filed_at: "2021-10-01T23:59:59+00:00"
generated_at: "2026-06-28T23:44:06.924433+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Interpace Biosciences extends maturity of $7.5M in secured notes to October 31, 2021

## Summary
- Ampersand Note principal $4.5M, 1315 Capital Note $3.0M; total $7.5M in secured debt.
- Maturity date extended one month from September 30, 2021 to October 31, 2021.
- This is the fourth amendment to each note; terms otherwise unchanged.
- Security agreement remains in full force and effect.
- Noteholders are related parties holding convertible preferred shares (39% and 26% fully diluted combined).

## SEC filing metadata
- accession: 0001493152-21-024381
- form_type: 8-K
- ticker: IDXG
- cik: 0001054102
- company_name: INTERPACE BIOSCIENCES, INC.
- filed_at: 2021-10-01T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1054102/000149315221024381/0001493152-21-024381-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1054102/000149315221024381/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-024381
- JSON: https://secwatch.observer/filing/0001493152-21-024381.json
- Plain text: https://secwatch.observer/filing/0001493152-21-024381.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.